Discrepant Antigen-specific Antibody Responses Causing SARS-CoV-2 Persistence in a Patient Receiving B-cell-targeted Therapy with Rituximab

A 73-year-old man previously treated with rituximab for his mucosa-associated lymphoid tissue lymphoma suffered a suboptimal humoral immune response against an acquired SARS-CoV-2 infection. A detailed serological description revealed discrepant antigen-specific humoral immune responses. The titer o...

Descripción completa

Detalles Bibliográficos
Autores principales: Takakuwa, Teruhito, Nakagama, Yu, Yasugi, Mayo, Maeda, Toshiki, Matsuo, Kenji, Kiritoshi, Ayako, Deguchi, Ryo, Hagawa, Naohiro, Shibata, Wataru, Oshima, Kazuhiro, Yamamoto, Katsumi, Uchida, Kenichiro, Noda, Tomohiro, Yamada, Koichi, Nishimura, Tetsuro, Yamamoto, Hiromasa, Kido, Yasutoshi, Hino, Masayuki, Kakeya, Hiroshi, Mizobata, Yasumitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710376/
https://www.ncbi.nlm.nih.gov/pubmed/34853259
http://dx.doi.org/10.2169/internalmedicine.7884-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710376/
https://www.ncbi.nlm.nih.gov/pubmed/34853259
http://dx.doi.org/10.2169/internalmedicine.7884-21

Ejemplares similares